Earnings were good to a few health companies, such as Immucor ( BLUD), but not as nice to others on a gloomy Thursday in the market. Immucor reported net income of $18.2 million, up 51% from $12.1 million for the same quarter last year. The company said it earned 26 cents a share. The Thomson Financial consensus target was 22 cents a share. The company gained $2.05, or 7.2%, to $30.63. Also up, Affymetrix ( AFFX) reported earnings after market close on Wednesday. The company said revenue rose 10% to $88.3 million, and it reported net income of $1.2 million, or 2 cents a share, compared with a loss of $10.1 million, or 15 cents a share, during the same period in 2006. Looking ahead, Affymetrix is predicting revenue from $365 million to $385 million for fiscal 2007, and gross margins around 60%. Shares climbed $1.44, or 5.8%, to $26.30. But on the down side, Bristol-Myers Squibb ( BMY) earned 37 cents a share, excluding one-time items, which is one penny better than the consensus of analysts polled by Thomson First Call. Revenue of $4.93 billion matched expectations. The company
raised guidance for the year, but investors seemed dissatisfied -- shares fell $1.33, or 4.2%, to $30.25. Bristol-Myers Squibb and AstraZeneca are both components of the Amex Pharmaceutical index, which was down 9.42, or 2.8%, to 340.44.
Palomar Medical Technologies ( PTMI) was among the falling Thursday. The stock gave up $6.36, or 16.5%, to $31.90. Palomar reported earning $5.8 million, or 30 cents a share, for the quarter, compared to $17.4 million, or 86 cents a share in the year-ago quarter. The company earned 43 cents a share before items, compared to 28 cents a share in the same period in 2006. Analysts surveyed by Thomson Financial expected 30 cents a share. Also, AstraZeneca ( AZN) released
second-quarter results , reporting earnings per share of $1.19, excluding one-time items, beating Wall Street estimates by 16 cents. It also divulged a plan to shuck 11% of its workforce within three years. The company's stock lost $2.60, or 4.7%, to $52.42. On the health-care services side, contenders such as Matria Healthcare ( MATR), Zimmer Holdings ( ZMH) and Express Scripts ( EXPS) all saw red on Thursday. For a wrap-up on these three companies, check out TheStreet.com's coverage . Matria lost $4.18, or 13.8%, to $26.15; Express Scripts gave up $2.28, or 4.4%, to $49.70; and Zimmer shed $6.85, or 7.9%, to $80.59.